We are live on ! Find out more
LGND icon

Ligand Pharmaceuticals
LGND

116 hedge funds and large institutions have $640M invested in Ligand Pharmaceuticals in 2013 Q2 according to their latest regulatory filings, with 116 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

3% less call options, than puts

Call options by funds: $4.19M | Put options by funds: $4.33M

Holders
116
Holders Change
+116
Holders Change %
–
% of All Funds
3.79%
Holding in Top 10
5
Holding in Top 10 Change
+5
Holding in Top 10 Change %
% of All Funds
0.16%
New
116
Increased
–
Reduced
–
Closed
–
Calls
$4.19M
Puts
$4.33M
Net Calls
-$140K
Net Calls Change
-$140K

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
BI
1
BVF Inc
California
$136M +$104M +5,805,529 New
DMK
2
David M. Knott
$54.3M +$41.9M +2,328,463 New
Fidelity Investments
3
Fidelity Investments
Massachusetts
$45.7M +$35.2M +1,957,401 New
UBS AM
4
UBS AM
Illinois
$42.9M +$33.1M +1,839,319 New
ACMM
5
Arbor Capital Management (Minnesota)
Minnesota
$31.4M +$24.2M +1,346,794 New
BIT
6
BlackRock Institutional Trust
California
$25.1M +$19.4M +1,077,014 New
BFA
7
BlackRock Fund Advisors
California
$23.6M +$18.2M +1,013,064 New
Wellington Management Group
8
Wellington Management Group
Massachusetts
$22.6M +$17.4M +966,024 New
Invesco
9
Invesco
Georgia
$21.8M +$16.8M +935,397 New
Vanguard Group
10
Vanguard Group
Pennsylvania
$20.3M +$15.7M +870,565 New
State Street
11
State Street
Massachusetts
$19.1M +$14.7M +817,726 New
Deutsche Bank
12
Deutsche Bank
Germany
$16.5M +$12.7M +706,543 New
PWAM
13
Park West Asset Management
California
$16.1M +$12.4M +690,893 New
SCA
14
SAC Capital Advisors
Connecticut
$11.9M +$9.14M +508,311 New
ACM
15
Ashford Capital Management
Delaware
$11.4M +$8.82M +490,613 New
Northern Trust
16
Northern Trust
Illinois
$10.9M +$8.37M +465,571 New
CM
17
Castleark Management
Illinois
$7.3M +$5.62M +312,721 New
PAM
18
Panagora Asset Management
Massachusetts
$6.91M +$5.33M +296,090 New
Wells Fargo
19
Wells Fargo
California
$6.47M +$4.99M +277,216 New
Allianz Asset Management
20
Allianz Asset Management
Germany
$6.36M +$4.9M +272,670 New
Prudential Financial
21
Prudential Financial
New Jersey
$5.24M +$4.04M +224,423 New
Macquarie Group
22
Macquarie Group
Australia
$4.68M +$3.6M +200,375 New
Bank of New York Mellon
23
Bank of New York Mellon
New York
$4.11M +$3.17M +176,162 New
TCM
24
Timpani Capital Management
Wisconsin
$4.03M +$3.11M +172,730 New
NCGI
25
Next Century Growth Investors
Minnesota
$3.88M +$2.99M +166,159 New
1
2 3 4 5

LGND Hedge Fund Activity: Q2 2013 in Review

116 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Ligand Pharmaceuticals (LGND) for Q2 2013, worth a combined $640M.

Buyers outnumbered sellers: 116 funds opened new LGND positions and 0 closed out — a net gain of 116 holders — while 0 added to existing stakes and 0 trimmed.

  • 116 institutional investors held Ligand Pharmaceuticals (LGND) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $640M of Ligand Pharmaceuticals stock for Q2 2013.
  • 116 funds opened new Ligand Pharmaceuticals positions in Q2 2013 and 0 closed out, a net change of +116 holders.

Based on aggregated 13F filings for Q2 2013.